Steffen reported recommendations for administration of the quadrivalent meningococcal vaccine (4V). The author is from the University of Zurich Centre for Travel Medicine and the University of Texas at Houston.
Parameters:
(1) meningococcal vaccination required
(2) time since any previous meningococcal vaccination
(3) occupation abroad
(4) destination
If the person has received the meningococcal vaccine within the past 3 years then revaccination is not required (unless a stay will be prolonged).
|
Vax Required |
Time Since |
Occupation |
Destination |
Action |
|
Yes |
never or >= 3 years |
NA |
NA |
vaccinate |
|
No |
never or >= 3 years |
humanitarian or military operation |
NA |
recommend vaccine |
|
No |
never or >= 3 years |
health profession |
NA |
consider vaccine |
|
No |
never or >= 3 years |
low risk |
epidemic or outbreak |
recommend vaccine |
|
No |
never or >= 3 years |
low risk |
AMB and high risk |
recommend |
|
No |
never or >= 3 years |
low risk |
AMB and low risk |
consider |
|
No |
never or >= 3 years |
low risk |
AMB and want protection |
recommend |
|
No |
never or >= 3 years |
low risk |
other |
consider |
where:
• Vaccination may be required to attend the Hajj, to travel in Umrah or parts of the Kingdom of Saudi Arabia, or to go to school at some universities.
• Humanitarian activities include disaster relief.
• AMB = African meningitis belt
• High risk in the African meningitis belt includes (1) prolonged contact with locals, (2) prolonged stay, (3) defect in host defenses
Specialty: Infectious Diseases, Pharmacology, clinical
ICD-10: ,
